| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/30/1999 | CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | CA2323063A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 09/30/1999 | CA2322779A1 Glycosyl sulfotransferase-3 |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0945134A1 New galenic formulations of meloxicam for oral administration |
| 09/29/1999 | EP0945132A2 Ibuprofen composition |
| 09/29/1999 | EP0945131A1 Peroral drug suspension |
| 09/29/1999 | EP0944720A1 Adaptor protein frs2 and related products and methods |
| 09/29/1999 | EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944636A1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944618A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944614A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/29/1999 | EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 09/29/1999 | EP0944587A1 Metalloproteinase inhibitors |
| 09/29/1999 | EP0944391A1 Use of equilenin as an antioxidant |
| 09/29/1999 | EP0944390A1 USE OF 17$g(b)-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230184A Arylamino fused pyridines and pyrimidines |
| 09/29/1999 | CN1230116A Pharmaceutical compsn. for treating viral diseases |
| 09/29/1999 | CN1230110A Cell adhesion inhibitors |
| 09/29/1999 | CN1045293C Substituted pyrazoles compounds and medicinal compositions containing same |
| 09/28/1999 | US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections |
| 09/28/1999 | US5958978 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 09/28/1999 | US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| 09/28/1999 | US5958882 Compounds that inhibit T cell proliferation and methods using the same |
| 09/28/1999 | US5958772 Antisense inhibition of cellular inhibitor of apoptosis-1 expression |
| 09/28/1999 | US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases |
| 09/28/1999 | US5958683 Screening method using the RZR receptor family |
| 09/28/1999 | US5958426 Sphingolipids and a process thereto |
| 09/28/1999 | US5958413 Pharmaceutical product for use in therapy or prophylaxis of disorders associated with elevated tumor necrosis factor levels, especially septic shock or endotoxic shock |
| 09/28/1999 | US5958410 Administering monoclonal antibody specific for epitope of variable region of specified t cell receptor chain |
| 09/28/1999 | US5958405 Human protein tyrosine kinase |
| 09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | CA2133503C Orally administrable opioid formulations having extended duration of effect |
| 09/28/1999 | CA2017029C Composition |
| 09/23/1999 | WO1999047708A1 Antisense modulation of pecam-1 |
| 09/23/1999 | WO1999047707A1 Antisense modulation of lfa-3 |
| 09/23/1999 | WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | WO1999047564A1 Fas-associated polypeptides |
| 09/23/1999 | WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047529A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | WO1999047524A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047517A1 Novel heterocyclic compounds |
| 09/23/1999 | WO1999047512A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 09/23/1999 | WO1999047132A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999039682A3 Lipid mixtures and their use |
| 09/23/1999 | WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 09/23/1999 | CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/23/1999 | CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2321155A1 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | CA2319493A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943683A1 Human vanilloid receptor homologue Vanilrep1 |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942931A2 Modulation of interactions between myosin and integrins |
| 09/22/1999 | EP0942925A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 09/22/1999 | EP0942903A1 Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| 09/22/1999 | EP0942902A2 Novel immunotherapeutic imides/amides |
| 09/22/1999 | EP0942896A1 Substituted phenols and thiophenols useful as antioxidant agents |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942745A1 Use of hyaluronidase |
| 09/22/1999 | EP0942740A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 09/22/1999 | EP0873050A4 Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| 09/22/1999 | EP0772615B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | EP0615522B1 Muramyl compounds for treatment of septic shock |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229407A Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels |
| 09/21/1999 | US5955462 Antiinflammatory agents for neurogenic inflammation and administering bisindole or compounds |
| 09/21/1999 | US5955457 Water soluble rapamycin esters |
| 09/21/1999 | US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are |
| 09/21/1999 | US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955303 Human chemokine receptor-like protein |
| 09/21/1999 | US5955282 Human galactosyltransferases |
| 09/21/1999 | US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents |
| 09/21/1999 | US5955104 Multiple unit oral pharmaceutical formulations |
| 09/21/1999 | CA2045761C Ws7622a mono- or di- sulfate, process for preparation thereof and use thereof |
| 09/19/1999 | WO1999041256A1 Glucocorticoid-selective anti-inflammatory agents |
| 09/19/1999 | CA2320943A1 Glucocorticoid-selective anti-inflammatory agents |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |